Activation of the IL-6R/Jak/Stat Pathway is Associated with a Poor Outcome in Resected Pancreatic Ductal Adenocarcinoma
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Activation of the IL-6R/Jak/Stat Pathway is Associated with a Poor Outcome in Resected Pancreatic Ductal Adenocarcinoma
Authors
Keywords
IL-6, Stat3, Jak, Pancreatic adenocarcinoma, Inflammation, Prognosis
Journal
JOURNAL OF GASTROINTESTINAL SURGERY
Volume 17, Issue 5, Pages 887-898
Publisher
Springer Nature
Online
2013-02-23
DOI
10.1007/s11605-013-2168-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Relationship Between Tumor Inflammatory Cell Infiltrate and Outcome in Patients with Pancreatic Ductal Adenocarcinoma
- (2012) Nigel B. Jamieson et al. ANNALS OF SURGICAL ONCOLOGY
- A Prospective Comparison of the Prognostic Value of Tumor- and Patient-Related Factors in Patients Undergoing Potentially Curative Surgery for Pancreatic Ductal Adenocarcinoma
- (2011) Nigel B. Jamieson et al. ANNALS OF SURGICAL ONCOLOGY
- The Unholy Trinity: Inflammation, Cytokines, and STAT3 Shape The Cancer Microenvironment
- (2011) Ning Li et al. CANCER CELL
- Stat3 and MMP7 Contribute to Pancreatic Ductal Adenocarcinoma Initiation and Progression
- (2011) Akihisa Fukuda et al. CANCER CELL
- Stat3/Socs3 Activation by IL-6 Transsignaling Promotes Progression of Pancreatic Intraepithelial Neoplasia and Development of Pancreatic Cancer
- (2011) Marina Lesina et al. CANCER CELL
- STAT3 Plays a Critical Role in KRAS-Induced Pancreatic Tumorigenesis
- (2011) R. B. Corcoran et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Combined Blockade of Src Kinase and Epidermal Growth Factor Receptor with Gemcitabine Overcomes STAT3-Mediated Resistance of Inhibition of Pancreatic Tumor Growth
- (2011) N. S. Nagaraj et al. CLINICAL CANCER RESEARCH
- STAT3 Expression, Molecular Features, Inflammation Patterns, and Prognosis in a Database of 724 Colorectal Cancers
- (2011) Teppei Morikawa et al. CLINICAL CANCER RESEARCH
- A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study
- (2011) Michael J. Proctor et al. EUROPEAN JOURNAL OF CANCER
- JAKs go nuclear: Emerging role of nuclear JAK1 and JAK2 in gene expression and cell growth
- (2011) Fouad A. Zouein et al. GROWTH FACTORS
- Crosstalk between the canonical NF-κB and Notch signaling pathways inhibits Pparγ expression and promotes pancreatic cancer progression in mice
- (2011) Eleni Maniati et al. JOURNAL OF CLINICAL INVESTIGATION
- Obesity and pancreatic cancer: Overview of epidemiologic evidence and biologic mechanisms
- (2011) Paige M. Bracci MOLECULAR CARCINOGENESIS
- Activation of the PIK3CA/AKT Pathway Suppresses Senescence Induced by an Activated RAS Oncogene to Promote Tumorigenesis
- (2011) Alyssa L. Kennedy et al. MOLECULAR CELL
- Taming the dragon: genomic biomarkers to individualize the treatment of cancer
- (2011) Ian J Majewski et al. NATURE MEDICINE
- STAT3 Knockdown Reduces Pancreatic Cancer Cell Invasiveness and Matrix Metalloproteinase-7 Expression in Nude Mice
- (2011) Hai dong Li et al. PLoS One
- Positive Mobilization Margins Alone Do Not Influence Survival Following Pancreatico-Duodenectomy for Pancreatic Ductal Adenocarcinoma
- (2010) Nigel B. Jamieson et al. ANNALS OF SURGERY
- Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells
- (2010) L. Lin et al. CANCER RESEARCH
- Nuclear Janus-Activated Kinase 2/Nuclear Factor 1-C2 Suppresses Tumorigenesis and Epithelial-to-Mesenchymal Transition by Repressing Forkhead Box F1
- (2010) J. Nilsson et al. CANCER RESEARCH
- Dual Roles for Immunity in Gastrointestinal Cancers
- (2010) Cristina Ferrone et al. JOURNAL OF CLINICAL ONCOLOGY
- Energy Balance, Host-Related Factors, and Cancer Progression
- (2010) Stephen D. Hursting et al. JOURNAL OF CLINICAL ONCOLOGY
- Signal Transducer and Activator of Transcription-3, Inflammation, and Cancer
- (2009) Bharat B. Aggarwal et al. Annals of the New York Academy of Sciences
- The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid Tumors
- (2009) Michael Hedvat et al. CANCER CELL
- Inflammation and Cancer: IL-6 and STAT3 Complete the Link
- (2009) Jacqueline Bromberg et al. CANCER CELL
- Targeting Inflammatory Pathways for Prevention and Therapy of Cancer: Short-Term Friend, Long-Term Foe
- (2009) B. B. Aggarwal et al. CLINICAL CANCER RESEARCH
- Targeting the hypoxia-inducible factor (HIF) pathway in cancer
- (2009) Evon Poon et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer
- (2009) J. P. Morton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer Statistics, 2008
- (2008) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Clinical Significance of Interleukin-6 (Il-6) Gene Polymorphism and Il-6 Serum Level in Pancreatic Adenocarcinoma and Chronic Pancreatitis
- (2008) Renata Talar-Wojnarowska et al. DIGESTIVE DISEASES AND SCIENCES
- Toxicogenomic Analysis of Mainstream Tobacco Smoke-Exposed Mice Reveals Repression of Plasminogen Activator Inhibitor-1 Gene in Heart
- (2008) Sabina Halappanavar et al. INHALATION TOXICOLOGY
- Insulin resistance, serum adiponectin, and proinflammatory markers in young subjects with the metabolic syndrome
- (2008) Irina Kowalska et al. METABOLISM-CLINICAL AND EXPERIMENTAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started